The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer
Open accessAbstract
Summary We report long-term outcomes on 1002 patients treated to 8640 cGy for localized prostate cancer using IMRT. High dose-escalation results in excellent tumor control with minimal toxicity when implementing strict dose constraints. Dose-escalation beyond 80 Gy is feasible and safe, and should be considered for select men with localized prostate cancer. Purpose To report the long-term survival and toxicity outcomes with the use of high dose intensity modulated radiation therapy (IMRT) to 86.4 Gy for patients with localized prostate cancer. Materials and Methods Between August 1997 and December 2008, 1002 patients were treated to a dose of 86.4 Gy using a 5–7 field IMRT technique. Patients were stratified into prognostic risk groups based on the National Comprehensive Cancer Network risk classification criteria. Five hundred eighty-seven patients (59%) were treated with neoadjuvant and concurrent androgen deprivation therapy (ADT). The median follow-up for the entire cohort was 5.5 years (range, 1–14 yrs). Results For low-, intermediate- and high-risk groups the 7-year biochemical relapse-free survival outcomes were 98.8%, 85.6%, and 67.9% (p<0.001), and distant metastasis-free survival rates of 99.4%, 94.1%, and 82.0% (p<0.001), respectively. On multivariate analysis T-stage (p<0.001), Gleason score (p<0.001), and >50% of initial biopsy cores positive (p=0.001) were predictive for DM. No prostate cancer related deaths were observed in the low-risk group. The 7-year prostate cancer–specific mortality (PCSM) using competing risk analysis for intermediate- and high-risk groups was 3.3% and 8.1%, respectively (p=0.008). On multivariate analysis Gleason score (p=0.004), percent biopsy core positivity (p=0.003), and T-stage (p=0.033) were predictive for PCSM. Actuarial 7-year grade 2 or higher late gastrointestinal and genitourinary toxicities were 4.4% and 21.1%, respectively. Late grade 3 gastrointestinal and genitourinary toxicity was experienced by 7 patients (0.7%) and 22 patients (2.2%), respectively. Of the 427 men with full potency at baseline, 317 men (74%) retained sexual function at time of last follow-up. Conclusions This represents the largest cohort of patients treated with high dose radiation to 86.4 Gy using IMRT for localized prostate cancer with the longest follow-up to date. Our findings indicate that this treatment results in excellent clinical outcomes with acceptable toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer
Kuban, D. A., Tucker, S. L., Dong, L., Starkschall, G., Huang, E. H., Cheung, M. R., Lee, A. K., & Pollack, A. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.054 · Cited by 1,232
Peeters, S. T. H., Heemsbergen, W. D., Koper, P. C. M., van Putten, W. L. J., Slot, A., Dielwart, M. F. H., Bonfrer, J. M. G., Incrocci, L., & Lebesque, J. V. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2530 · Cited by 966
Dearnaley, D. P., Sydes, M. R., Graham, J. D., Aird, E. G., Bottomley, D., Cowan, R. A., Huddart, R. A., Jose, C. C., Matthews, J. H., Millar, J., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70143-2 · Cited by 905
Zelefsky, M. J., Fuks, Z., Hunt, M., Yamada, Y., Marion, C., Ling, C. C., Amols, H., Venkatraman, E. S., & Leibel, S. A. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02857-2 · Cited by 775
Self-citationZietman, A. L., Bae, K., Slater, J. D., Shipley, W. U., Efstathiou, J. A., Coen, J. J., Bush, D. A., Lunt, M., Spiegel, D. Y., Skowronski, R., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8475 · Cited by 735
ZELEFSKY, M. J., FUKS, Z., HUNT, M., LEE, H. J., LOMBARDI, D., LING, C. C., REUTER, V. E., VENKATRAMAN, E. S., & LEIBEL, S. A. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65855-7 · Cited by 697
Self-citationClinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer
Zelefsky, M. J., Fuks, Z., Happersett, L., Lee, H. J., Ling, C. C., Burman, C. M., Hunt, M., Wolfe, T., Venkatraman, E. S., Jackson, A., et al. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00100-0 · Cited by 543
Self-citationViani, G. A., Stefano, E. J., & Afonso, S. L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.091 · Cited by 469
Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes
Cahlon, O., Zelefsky, M. J., Shippy, A., Chan, H., Fuks, Z., Yamada, Y., Hunt, M., Greenstein, S., & Amols, H. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.10.004 · Cited by 277
Self-citationDose response in prostate cancer with 8–12 years’ follow-up
Hanks, G. E., Hanlon, A. L., Epstein, B. E., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02954-1 · Cited by 194
Cited by
Dearnaley, D. P., Jovic, G., Syndikus, I., Khoo, V., Cowan, R. A., Graham, J. D., Aird, E. G., Bottomley, D., Huddart, R. A., Jose, C. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70040-3 · Cited by 463
Epstein, J. I., Amin, M. B., Fine, S. W., Algaba, F., Aron, M., Baydar, D. E., Beltran, A. L., Brimo, F., Cheville, J. C., Colecchia, M., et al. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0015-ra · Cited by 280
Metadata
- Authors
- Spratt, D. E., Pei, X., Yamada, J., Kollmeier, M. A., Cox, B., & Zelefsky, M. J.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 85
- Issue
- 3
- Pages
- 686-692
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W2127755970
- Cited by
- 261
- References
- 16
- FWCI
- 22.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer. https://app.cochat.ai/papers/10.1016/j.ijrobp.2012.05.023
- The paper
- Spratt, D. E., Pei, X., Yamada, J., Kollmeier, M. A., Cox, B., & Zelefsky, M. J. (2013). Long-term Survival and Toxicity in Patients Treated With High-Dose Intensity Modulated Radiation Therapy for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2012.05.023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.